Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: Effects on virus replication and recurrent hepatitis

Table 1 Baseline characteristics of 47 HCV-infected patients after LTx, orthotopic liver transplantation (OLT), and living donor liver transplantation (LDLT)

	CsA	Tac	P-value
Number of patients	35	12
Age	28-64	27-61	0,20
Gender	F = 9, m = 26	F = 3, m = 9	0.96
OLT	31	10
LDLT	4	2	0.64
HCV genotype	gt1 = 32/35,	gt1 = 10/12,	0.46
	gt2 = 1/35,	gt2 = 0/12,
	gt3 = 2/35	gt3 = 2/12

Table 2 Net group difference (CsA vs FK 506) of changes in virus load (log₁₀-scale) between pre-LTx measurement and indicated time points post LTx

Mo	Mean	95%CI	P-value1
1	0.40	(–0.28; 1.08)	0.11
3	–0.50	(–1.46; 0.47)	0.49
6	–0.43	(–1.50; 0.64)	0.72
12	–0.56	(–1.64; 0.52)	0.49

¹Mann–Whitney U test.